- Home
- ASTC vs TENX Comparison
ASTC vs TENX Comparison
Compare ASTC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- TENX
- Stock Information
- Founded
- ASTC 1984
- TENX 1967
- Country
- ASTC United States
- TENX United States
- Employees
- ASTC N/A
- TENX N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- TENX Health Care
- Exchange
- ASTC Nasdaq
- TENX Nasdaq
- Market Cap
- ASTC 11.9M
- TENX 19.5M
- IPO Year
- ASTC 1995
- TENX N/A
- Fundamental
- Price
- ASTC $7.27
- TENX $5.61
- Analyst Decision
- ASTC
- TENX Strong Buy
- Analyst Count
- ASTC 0
- TENX 4
- Target Price
- ASTC N/A
- TENX $20.67
- AVG Volume (30 Days)
- ASTC 39.8K
- TENX 67.4K
- Earning Date
- ASTC 02-10-2025
- TENX 11-13-2024
- Dividend Yield
- ASTC N/A
- TENX N/A
- EPS Growth
- ASTC N/A
- TENX N/A
- EPS
- ASTC N/A
- TENX N/A
- Revenue
- ASTC $1,273,000.00
- TENX N/A
- Revenue This Year
- ASTC N/A
- TENX N/A
- Revenue Next Year
- ASTC N/A
- TENX N/A
- P/E Ratio
- ASTC N/A
- TENX N/A
- Revenue Growth
- ASTC 11.96
- TENX N/A
- 52 Week Low
- ASTC $6.56
- TENX $2.77
- 52 Week High
- ASTC $12.29
- TENX $27.36
- Technical
- Relative Strength Index (RSI)
- ASTC 50.55
- TENX 54.30
- Support Level
- ASTC $7.04
- TENX $5.70
- Resistance Level
- ASTC $8.15
- TENX $6.01
- Average True Range (ATR)
- ASTC 0.47
- TENX 0.47
- MACD
- ASTC 0.05
- TENX -0.08
- Stochastic Oscillator
- ASTC 43.23
- TENX 12.15
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.